economic climate

R&D
light at the end of the tunnel

Brighter times ahead for biotech in 2024?

The biotech industry experienced heady highs in early 2021, but has since suffered from a tight financial climate that has brought bankruptcies and widespread redundancies.

Market Access
M&A

A year of major M&A ahead?

The previous few years have seen a slowdown in M&A across the industry, as companies take a cautious approach to expansion.